1. Home
  2. EVO vs BMEZ Comparison

EVO vs BMEZ Comparison

Compare EVO & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.42

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Health Sciences Term Trust of Beneficial Interest

BMEZ

BlackRock Health Sciences Term Trust of Beneficial Interest

HOLD

Current Price

$14.09

Market Cap

871.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
BMEZ
Founded
1993
N/A
Country
Germany
United States
Employees
4766
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
821.2M
871.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
EVO
BMEZ
Price
$2.42
$14.09
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
105.5K
213.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$12.58
52 Week High
$4.80
$15.80

Technical Indicators

Market Signals
Indicator
EVO
BMEZ
Relative Strength Index (RSI) 27.25 30.10
Support Level N/A $14.07
Resistance Level $3.78 $14.29
Average True Range (ATR) 0.10 0.20
MACD -0.10 -0.08
Stochastic Oscillator 8.81 12.70

Price Performance

Historical Comparison
EVO
BMEZ

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest

BlackRock Health Sciences Term Trust is a closed-end fund focused on the healthcare and health sciences sector. Its investment objectives are to provide total return and income through long-term capital appreciation.

Share on Social Networks: